| abstract |
A therapeutic agent for cancer-associated neuropathy and AZOOR or related diseases thereof, which contains, as an active ingredient, a calcium antagonist, particularly a dihydropyridine compound represented by the general formula (I): n n n wherein R 1 represents nitrophenyl, and R 2 , R 3 and R 4 each represents a lower alkyl group, or a salt thereof. |